A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer

por Boutros, C, Mazouni, C, Lerebours, F, Stevens, D, Lei, X, Gonzalez-Angulo, A M, Delaloge, S
Publicado 2015

Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer

por Porte, B., Carton, M., Lerebours, F., Brain, E., Loirat, D., Haroun, L., Bellesoeur, A., Bach Hamba, S., Kirova, Y., Cottu, P.
Publicado 2020

Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models

por Laas, E, Mallon, P, Delomenie, M, Gardeux, V, Pierga, J-Y, Cottu, P, Lerebours, F, Stevens, D, Rouzier, R, Reyal, F
Publicado 2015

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma

por Rossi, L, Laas, E, Mallon, P, Vincent-Salomon, A, Guinebretiere, J-M, Lerebours, F, Rouzier, R, Pierga, J-Y, Reyal, F
Publicado 2015

Hemoglobin overexpression and splice signature as new features of inflammatory breast cancer?

por Lerebours, F., Vacher, S., Guinebretiere, J.M., Rondeau, S., Caly, M., Gentien, D., Van Laere, S., Bertucci, F., de la Grange, P., Bièche, l., Liang, X., Callens, C.
Publicado 2020

High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study

por Cottu, P H, Extra, J M, Espie, M, Marolleau, J P, Roquancourt, A de, Makke, J, Miclea, J M, Laurence, V, Mayeur, D, Lerebours, F, Cuvier, C, Marty, M
Publicado 2001

Compliance to genomic test recommendations to guide adjuvant chemotherapy decision‐making in the case of hormone receptor‐positive, human epidermal growth factor receptor 2‐negativ...

por Hequet, D., Hajjaji, N., Charafe‐Jauffret, E., Boucrauta, A., Dalenc, F., Nicolai, V., Lopez, J., Tredan, O., Deluche, E., Fermeaux, V., Tixier, L., Cayre, A., Menet, E., Lerebours, F., Rouzier, R.
Publicado 2023

Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)

por Dano, D., Lardy-Cleaud, A., Monneur, A., Quenel-Tueux, N., Levy, C., Mouret-Reynier, M.-A., Coudert, B., Mailliez, A., Ferrero, J.-M., Guiu, S., Campone, M., de La Motte Rouge, T., Petit, T., Pistilli, B., Dalenc, F., Simon, G., Lerebours, F., Chabaud, S., Bertucci, F., Gonçalves, A.
Publicado 2021

A refined molecular taxonomy of breast cancer

por Guedj, M, Marisa, L, de Reynies, A, Orsetti, B, Schiappa, R, Bibeau, F, MacGrogan, G, Lerebours, F, Finetti, P, Longy, M, Bertheau, P, Bertrand, F, Bonnet, F, Martin, A L, Feugeas, J P, Bièche, I, Lehmann-Che, J, Lidereau, R, Birnbaum, D, Bertucci, F, de Thé, H, Theillet, C
Publicado 2012